AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
DCV-I dendritic cell therapy product receives CE mark.(Brief Article)
2002 APR 17 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM), announced that it has obtained approval to affix the CE Mark to the new DCV-I Cell Therapy Kit (DCV-I), permitting its marketing and sale in Europe.
The DCV-I product provides the automated, GMP-compliant production of a complete antigen-loaded dendritic cell vaccine, based on Aastrom's proprietary cultured dendritic cell, the Dendricell. The DCV-I joins the company's lead dendritic cell product, the DC-I.
The DCV-I product will be immediately available through commercial relationships to clinical investigators and companies active in dendritic cell vaccine research and development.
"While there are numerous antigen approaches being explored to create vaccines, all require a highly active dendritic cell produced under conditions required by regulatory authorities," said R. Douglas Armstrong, PhD, president and CEO of Aastrom. "The DCV-I and DC-I products specifically address this market need, and may be used in virtually all cultured dendritic cell vaccine approaches. These 2 products give Aastrom ...
- DCV-I dendritic cell therapy product receives CE mark.(Aastrom Biosciences Inc....
- Newspaper article from: Immunotherapy Weekly April 17, 2002 700+ words
...dendritic cell vaccine, based on Aastrom's proprietary cultured dendritic cell, the Dendricell. The DCV-I joins the company's lead dendritic cell product, the DC-I. The DCV-I product will be immediately available through commercial relationships...
- SPINOUT DCV TECH FOCUSING ON DENDRITIC-CELL CANCER VACCINES By Karen Pihl-Carey...
- Magazine article from: BIOWORLD Today September 3, 2004 700+ words
...like," said Martin Cannon, DCV's vice president and director...university gained patent coverage. DCV evolved with the combination...company initially is focusing on dendritic-cell vaccines to treat gynecological...chemotherapy or radiation." DCV does not intend to replace chemotherapy...
- Aastrom Biosciences Completes Second CE Marked Dendritic Cell Therapy Product;...
- Press release article from: PR Newswire February 14, 2002 700+ words
...Aastrom's proprietary cultured dendritic cell, the Dendricell(TM). The DCV-I joins the Company's lead dendritic cell product, the DC-I, in providing...In addition, the DC-I and DCV-I dendritic cell production products have recently...
- Aastrom Biosciences Completes CE Mark Requirements for Third Dendritic Cell...
- Press release article from: PR Newswire August 21, 2003 700+ words
...affix the CE Mark on its DCV-II kit in the European...third of the Company's dendritic cell production kits to use the CE Mark. The DCV-II kit operates on...cancer vaccines and the DCV-I kit, intended for...complete antigen-loaded dendritic cell vaccines. Aastrom has...
- Aastrom's Dendritic Cell Vaccine Technology to Be Utilized in Duke University's...
- Press release article from: PR Newswire December 11, 2003 700+ words
...produced using Aastrom's DCV-II dendritic cell vaccine production kit...and three disposable dendritic cell production kits (DC-I, DCV-I and DCV-II) provide...System, along with the DCV-II dendritic cell production kit, will...
- CE Mark requirements completed for third dendritic cell therapy product.
- Newspaper article from: Biotech Business Week September 15, 2003 700+ words
...affix the CE Mark on its DCV-II kit in the European...third of the company's dendritic cell production kits to use the CE Mark. The DCV-II kit operates on...Aastrom's technology. "Dendritic cell-based cancer vaccine...the United States. The DCV-II kit meets the need...
- Aastrom Biosciences Receives NIH Grant for Dendritic Cell Vaccine Research; --...
- Press release article from: PR Newswire September 15, 2003 700+ words
...of an array of different dendritic cell-based vaccines for patient therapy. Dendritic cell antigen loading strategies...marking in Europe of its third dendritic cell product, designated DCV-II, for the automated...
- NIH grant to be used for dendritic cell vaccine research.
- Newspaper article from: Immunotherapy Weekly October 15, 2003 700+ words
...of an array of different dendritic cell-based vaccines for patient therapy. Dendritic cell antigen loading strategies...marking in Europe of its third dendritic cell product, designated DCV-II, for the automated...